🔎 Trials Near Me

Gara Jalqabaatti › Dhibee Seli Sikiilii › Illinois › Chicago

Qorannoo klinikaalii Dhibee Seli Sikiilii Chicago, IL keessatti

Qorannoo 18 Dhibee Seli Sikiilii f Chicago fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)

Namoota walitti qabaa jiraSadarkaa 1
  • University of Illinois Hospital and Health Sciences System, Chicago
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07187973

A Study of Nicotinamide With Oral Tetrahydrouridine and Decitabine to Treat High Risk Sickle Cell Disease

Namoota walitti qabaa jiraSadarkaa 1
  • University of Illinois at Chicago College of Medicine, Chicago
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT04055818

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

Namoota walitti qabaa jiraSadarkaa 3
  • Uni of Illinois Hospital and HSC, Chicago
Umuriin 12 hanga 100 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06439082

A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

Namoota walitti qabaa jiraSadarkaa 3
  • Univer Of Illinois at Chicago, Chicago
Umuriin 2 fi ol · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT06609226

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

Namoota walitti qabaa jiraSadarkaa 3
  • Childrens Hospital of Chicago, Chicago
  • Univer Of Illinois at Chicago, Chicago
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT06612268

Tocilizumab for Acute Chest Syndrome

Namoota walitti qabaa jiraSadarkaa 2
  • University of Chicago, Chicago
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT05640271

A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD

Namoota walitti qabaa jiraSadarkaa 2/3
  • University of Illinois at Chicago Clinical Research Center, Chicago
  • University of Illinois Hospital and Health Sciences System - Investigational Drug Services (IDS), Chicago
  • University of Illinois Hospital and Health Sciences System, Chicago
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 18-Hag-2026 · NCT05431088

A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease

Namoota walitti qabaa jiraSadarkaa 1/2Hojjettoota fayyaa simatamoo
  • Local Institution - 0034, Chicago
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Hag-2026 · NCT06481306

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Rush University Medical Center, Chicago
Umuriin hundi · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT04398628

Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

Namoota walitti qabaa jiraSadarkaa 2
  • University of Illinois at Chicago, Chicago
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 14-Hag-2026 · NCT06699849

The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease

Namoota walitti qabaa jiraSadarkaa 3
  • University of Illinois-Chicago - College of Medicine- Site Number : 8400054, Chicago
Umuriin 10 hanga 65 · Saalaa hunda · Haaromfame 29-Ado-2026 · NCT06975865

Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease

Namoota walitti qabaa jiraSadarkaa 2
  • University of Illinois at Chicago, Chicago
Umuriin 16 hanga 60 · Saalaa hunda · Haaromfame 08-Ado-2026 · NCT03121001

Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Comer Children's Hospital (MRD-HCT), Chicago
Umuriin 3 hanga 20 · Saalaa hunda · Haaromfame 04-Wax-2026 · NCT06941389

Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin

Namoota walitti qabaa jiraSadarkaa 2
  • University of Illinois Chicago, Sickle Cell Center, Chicago
Umuriin 18 hanga 60 · Saalaa hunda · Haaromfame 19-Cam-2026 · NCT07175051

Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease

Namoota walitti qabaa jira
  • University of Illinois at Chicago, Chicago
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Bit-2026 · NCT06919224

Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease

Namoota walitti qabaa jiraSadarkaa 2
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Umuriin 2 hanga 25 · Saalaa hunda · Haaromfame 10-Bit-2026 · NCT03587272

Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain

Namoota walitti qabaa jira
  • Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago
Umuriin 16 hanga 30 · Saalaa hunda · Haaromfame 07-Ama-2026 · NCT06374238

Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease

Namoota walitti qabaa jiraQorannoo ilaalaa
  • University of Illinois, Chicago
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Wax-2025 · NCT06385886

Qorannoo Dhibee Seli Sikiilii magaalota biroo keessatti

Qorannoo biroo Chicago keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.